Key Financial Data Of Reporting Company

Oncolys BioPharma Inc. - Filing #7587326

Concept As at
2022-09-30
2022-01-01 to
2022-09-30
2022-07-01 to
2022-09-30
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-09-30
As at
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
784,509,000 JPY
642,494,000 JPY
318,317,000 JPY
Ordinary profit (loss)
-854,455,000 JPY
-1,500,888,000 JPY
-976,891,000 JPY
Profit (loss)
-835,248,000 JPY
-1,615,439,000 JPY
-979,679,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
3,000,000,000 JPY
9,039,516,000 JPY
9,000,735,000 JPY
Total number of issued shares
17,405,200 xbrli:shares
17,405,200 xbrli:shares
17,341,100 xbrli:shares
Net assets
2,472,958,000 JPY
3,593,992,000 JPY
4,152,227,000 JPY
Total assets
3,455,544,000 JPY
4,291,876,000 JPY
4,883,402,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-48.20
-15.43
-95.50
-58.42
-19.00
Diluted earnings per share
Equity-to-asset ratio
0.713 xbrli:pure
0.836 xbrli:pure
0.849 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.